Brainstorm cell therapeutics appoints nir naor as board member and audit committee chair

New york , june 20, 2023 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced the appointment of nir naor, cpa, cfa, mba (imd), ll.m, as board member, chairman of its audit committee and member of its governance, nomination and compensation committee (gnc), effective june 20. mr. naor is replacing mr.
BCLI Ratings Summary
BCLI Quant Ranking